Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
Syndax Pharmaceuticals Inc (SNDX)
Standardized SEC financial data for Syndax Pharmaceuticals Inc — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001395937 · NASDAQ · Pharmaceutical Preparations.
Operating margin
-158.4%
Net margin
-165.6%
Revenue growth (YoY)
627.8%
Return on equity
-441.6%
ROIC
-77.1%
Free cash flow
-$323.2M
Debt / equity
5.42×
Current ratio
4.40×
Ratios for fiscal year 2025, standardized from SEC filings.